In one of its premiere transactions since the opening of the European Investment Bank’s regional office in Bulgaria in 2017, Spasov & Bratanov successfully advised the European Investment Bank in relation to a EUR 100,000,000 credit facility made available to Biovet AD – manufacturer and marketer of medicated and nutritional feed additives, part of the Huvepharma pharmaceutical group. Biovet AD will utilize the financing to fuel the construction of a new production plant in Peshtera, Bulgaria. It is expected that with the commissioning of the new facility in the end of this year, Biovet AD will create 150 new jobs in Peshtera and overall expand its production capabilities in Bulgaria with 50%. Allen & Overy acted as English and Luxemburg counsel with Spasov & Bratanov providing Bulgarian law advice on all aspects of the financing. This milestone transaction is yet another clear indicator of the leading position that the firms’ banking and finance practice enjoys on the Bulgarian market. Our highly experienced team consisted of Counsel Nadia Hadjova, assisted by Nayden and Irina.

Date: April 2018

Source: Spasov & Bratanov Lawyers’ Partnership

PRACTICES

More Posts

Spasov and Bratanov has advised VP Brands International AD on its acquisition of 100% of

Read More »

Spasov and Bratanov has advised Impetus Capital AD, through the investment fund ImVenture II KDA,

Read More »

Spasov and Bratanov advises Impetus Capital and ImVenture II with the investment in the Delaware

Read More »

Spasov and Bratanov was once again entrusted with providing legal support to ImVenture II KDA,

Read More »

Share: